FDA approves first pill to treat postpartum depression, 2023 Lawsuit: Scam or Legit? Find Out!

Did you receive a mail about a class action settlement concerning FDA approval for the first pill to treat postpartum depression? This review will help you partake in the class action settlement after confirming the authenticity of the mail.

What Is FDA approval for first pill to treat postpartum depression Lawsuit?

The U.S. Food and Drug Administration (FDA) has approved the drug Zuranolone to be sold under the brand name Zurzuvae as the first oral medication that can be used to treat postpartum depression in adults. 

The FDA said access to an oral medication for postpartum depression can help women who are dealing with the depressive condition. 

What Is This Class Action All About?

The U.S. Food and Drug Administration (FDA) announced Aug. 4 that it has approved the first oral medication for treating postpartum depression in adults. 

Treatment for postpartum depression was previously limited to IV injections that could only be administered by health care providers in certain healthcare facilities, according to the FDA. 

“Having access to an oral medication will be a beneficial option for many … women coping with extreme, and sometimes life-threatening, feelings,” said Tiffany R. Farchione, M.D., director of the Division of Psychiatry in the FDA’s Center for Drug Evaluation and Research, in a statement. 

Postpartum depression is characterized by feelings of sadness or loss of interest in activities that an individual used to enjoy, along with a decreased feeling of pleasure overall, according to the FDA.

Farchione, meanwhile, called postpartum depression a “serious and potentially life-threatening condition” that can cause women to experience negative thoughts, and, in severe cases, make them consider hurting themselves or their child. 

“Postpartum depression is a serious and potentially life-threatening condition in which women experience sadness, guilt, worthlessness—even, in severe cases, thoughts of harming themselves or their child,” Farchione said. 

Who Is Eligible?

This settlement benefits all persons who thinks they can benefit from taking the newly FDA approved oral medication for treating postpartum depression.

How To Be Part of This Settlement

To partake in this settlement, class member must submit a valid and timely claim on the settlement website.

What Is The Pay For This Settlement?

The pay for this settlement varies and the proof of purchase is not necessary.

Conclusion

As you submit your claim to the settlement website, just like Iowa Board of Regents class action settlement we have reviewed, you’re doing so under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim.

Leave a Comment

error: Content is protected !!